Ziemann M - Search Results

1

High prevalence of cytomegalovirus DNA in plasma samples of blood donors in connection with seroconversion.

Ziemann M, Krueger S, Maier AB, Unmack A, Goerg S, Hennig H. Ziemann M, et al. Transfusion. 2007 Nov;47(11):1972-83. doi: 10.1111/j.1537-2995.2007.01420.x. Transfusion. 2007. PMID: 17958525

2

Selection of whole-blood donors for hemoglobin testing by use of historical hemoglobin values.

Ziemann M, Steppat D, Brockmann C, Washington G, Kirchner H, Schlenke P. Ziemann M, et al. Transfusion. 2006 Dec;46(12):2176-83. doi: 10.1111/j.1537-2995.2006.01049.x. Transfusion. 2006. PMID: 17176332

3

Increased mortality in long-term intensive care patients with active cytomegalovirus infection.

Ziemann M, Sedemund-Adib B, Reiland P, Schmucker P, Hennig H. Ziemann M, et al. Crit Care Med. 2008 Dec;36(12):3145-50. doi: 10.1097/CCM.0b013e31818f3fc4. Crit Care Med. 2008. PMID: 18936696

4

The natural course of primary cytomegalovirus infection in blood donors.

Ziemann M, Unmack A, Steppat D, Juhl D, Görg S, Hennig H. Ziemann M, et al. Vox Sang. 2010 Jul 1;99(1):24-33. doi: 10.1111/j.1423-0410.2009.01306.x. Epub 2010 Jan 13. Vox Sang. 2010. PMID: 20074081

5

A novel set of real-time PCRs for rapid differentiation between human cytomegalovirus wild-type and highly passaged laboratory strains.

Ziemann M, Unmack A, Hennig H. Ziemann M, et al. J Virol Methods. 2010 Dec;170(1-2):155-9. doi: 10.1016/j.jviromet.2010.09.020. Epub 2010 Sep 29. J Virol Methods. 2010. PMID: 20887751

6

Evaluation of algorithms for the diagnostic assessment and the reentry of blood donors who tested reactive for antibodies against hepatitis B core antigen.

Juhl D, Luhm J, Görg S, Ziemann M, Hennig H. Juhl D, et al. Among authors: ziemann m. Transfusion. 2011 Jul;51(7):1477-85. doi: 10.1111/j.1537-2995.2010.03031.x. Epub 2011 Jan 28. Transfusion. 2011. PMID: 21276000

7

Reliability of capillary hemoglobin screening under routine conditions.

Ziemann M, Lizardo B, Geusendam G, Schlenke P. Ziemann M, et al. Transfusion. 2011 Dec;51(12):2714-9. doi: 10.1111/j.1537-2995.2011.03183.x. Epub 2011 May 20. Transfusion. 2011. PMID: 21599674

8

Window period donations during primary cytomegalovirus infection and risk of transfusion-transmitted infections.

Ziemann M, Heuft HG, Frank K, Kraas S, Görg S, Hennig H. Ziemann M, et al. Transfusion. 2013 May;53(5):1088-94. doi: 10.1111/trf.12074. Epub 2013 Jan 16. Transfusion. 2013. PMID: 23320406

9

Comparison of the two fully automated anti-HCMV IgG assays: Abbott Architect CMV IgG assay and Biotest anti-HCMV recombinant IgG ELISA.

Juhl D, Vockel A, Luhm J, Ziemann M, Hennig H, Görg S. Juhl D, et al. Among authors: ziemann m. Transfus Med. 2013 Jun;23(3):187-94. doi: 10.1111/tme.12036. Epub 2013 Apr 11. Transfus Med. 2013. PMID: 23578169

10

The impact of donor cytomegalovirus DNA on transfusion strategies for at-risk patients.

Ziemann M, Juhl D, Görg S, Hennig H. Ziemann M, et al. Transfusion. 2013 Oct;53(10):2183-9. doi: 10.1111/trf.12199. Epub 2013 Apr 15. Transfusion. 2013. PMID: 23581526

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

145 results

Search Page

Filters